Unlock AI-driven, actionable R&D insights for your next breakthrough.

Polyethylene Glycol 300: Comprehensive Analysis Of Molecular Structure, Synthesis, And Industrial Applications

MAR 25, 202667 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Polyethylene Glycol 300 (PEG 300) is a low-molecular-weight polyether polymer with an average molecular weight of approximately 300 g/mol, consisting predominantly of oligomers with 5 to 9 ethylene oxide repeating units 1. This water-soluble, non-toxic polymer exhibits unique physicochemical properties including hygroscopicity, low volatility, and excellent solubilizing capacity, making it indispensable across pharmaceutical, cosmetic, food, and industrial applications 3. PEG 300 represents a critical member of the polyethylene glycol family, bridging the gap between lower molecular weight glycols and higher molecular weight solid PEGs, with a glass transition temperature ranging from 4–8°C 18.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Composition And Structural Characteristics Of Polyethylene Glycol 300

Polyethylene Glycol 300 possesses the general chemical structure HO-(CH₂-CH₂-O)ₙ-H, where the average value of n corresponds to approximately 5 to 9 repeating ethylene oxide units 1. This polydisperse nature is fundamental to understanding PEG 300's behavior, as commercial preparations contain a distribution of oligomeric species rather than a single molecular entity 3. Mass spectrometry analysis reveals that PEG 300 comprises multiple oligomers with molecular weights centered around the nominal 300 g/mol value, with the distribution following a Poisson pattern 1. The polydispersity index (PDI) typically ranges from 1.05 to 1.15, indicating relatively narrow molecular weight distribution compared to higher molecular weight PEGs 6.

The hydroxyl terminal groups at both ends of the polymer chain confer significant reactivity, enabling chemical modification for specialized applications 9. These terminal hydroxyl groups exhibit pKa values around 15, making them susceptible to activation by strong bases or reactive electrophiles 3. The ether linkages (-O-) in the backbone provide conformational flexibility and contribute to the polymer's hydrophilicity through hydrogen bonding with water molecules 4. Nuclear magnetic resonance (NMR) spectroscopy confirms the predominant presence of -CH₂-CH₂-O- repeating units with characteristic chemical shifts at δ 3.6-3.7 ppm for the methylene protons adjacent to oxygen atoms 7.

The molecular weight specification for PEG 300 follows industry standards requiring the number average molecular weight (Mₙ) to be within 5% of the labeled nominal value for polyethylene glycols below 1000 g/mol 67. Gel Permeation Chromatography (GPC) or Size Exclusion Chromatography (SEC) using polystyrene calibration standards typically measures Mw values between 285-315 g/mol for commercial PEG 300 products 17. This molecular weight range positions PEG 300 as a liquid at room temperature with viscosity approximately 60-80 cP at 25°C, significantly lower than higher molecular weight PEG variants 11.

Polydispersity And Oligomer Distribution In PEG 300

The polydisperse composition of PEG 300 presents both advantages and challenges for industrial applications 1. Full-scan mass spectrometry demonstrates that PEG 300 contains oligomers ranging from triethylene glycol (n=2, MW≈150) to dodecaethylene glycol (n=11, MW≈500), with maximum abundance at hexaethylene glycol (n=5, MW≈282) and heptaethylene glycol (n=6, MW≈326) 1. This distribution results from the base-catalyzed ring-opening polymerization mechanism used in commercial production, where ethylene oxide addition to initiator diols proceeds statistically 67.

The presence of low molecular weight species, particularly ethylene glycol (EG) and diethylene glycol (DEG), requires careful control in pharmaceutical-grade PEG 300 6. United States Pharmacopeia (USP) specifications limit ethylene glycol and diethylene glycol content to ≤0.25% (2,500 ppm) for PEGs with molecular weight ≤1000 g/mol intended for biomedical applications 67. These low molecular weight oligomers may interact with hepatic metabolism pathways, necessitating purification processes such as vacuum distillation or molecular sieve separation to achieve pharmaceutical compliance 6. High-performance liquid chromatography (HPLC) with refractive index (RI) detection provides quantitative analysis of oligomer distribution, enabling quality control verification 1.

Advanced purification techniques can reduce oligomer heterogeneity, though complete monodispersity remains economically impractical for commodity PEG 300 3. Chromatographic fractionation methods can isolate specific oligomers, but the term "monodisperse PEG" in patent literature often refers to fractions with narrowed molecular weight distributions (PDI <1.05) rather than true single-species preparations 1. For most industrial applications, the inherent polydispersity of PEG 300 does not compromise performance and may actually enhance certain properties such as solubilization capacity and plasticizing effects 816.

Synthesis Routes And Production Methods For Polyethylene Glycol 300

Commercial production of PEG 300 relies predominantly on base-catalyzed ring-opening polymerization of ethylene oxide, a well-established industrial process offering high yields and scalability 67. The reaction initiates by adding ethylene oxide gas to a diol starter molecule (typically ethylene glycol or diethylene glycol) in the presence of alkaline catalysts such as sodium hydroxide (NaOH) or potassium hydroxide (KOH) at elevated temperatures (120-180°C) and pressures (2-5 bar) 34. The catalyst concentration typically ranges from 0.1-0.5 wt%, with reaction times of 4-8 hours depending on target molecular weight and reactor configuration 7.

The polymerization mechanism proceeds through nucleophilic attack of alkoxide ions (generated by deprotonation of hydroxyl groups) on the strained three-membered ethylene oxide ring, resulting in ring opening and chain propagation 6. The statistical nature of this process generates the characteristic Poisson distribution of oligomer lengths observed in commercial PEG 300 13. Temperature control is critical, as excessive temperatures (>200°C) promote side reactions including ether cleavage and formation of cyclic oligomers (crown ethers), which reduce yield and complicate purification 7. Pressure regulation ensures adequate ethylene oxide concentration in the liquid phase while preventing runaway polymerization 6.

Following polymerization, the crude product undergoes neutralization with acids (typically phosphoric acid or acetic acid) to deactivate the base catalyst and prevent post-polymerization degradation 7. Residual catalyst salts are removed by filtration or centrifugation, followed by vacuum stripping at 80-120°C to eliminate unreacted ethylene oxide, water, and low-boiling oligomers 6. For pharmaceutical-grade PEG 300, additional purification steps include activated carbon treatment to remove color bodies, molecular sieve adsorption to reduce low molecular weight impurities, and final filtration through 0.2-0.45 μm membranes 67.

Alternative Synthesis Approaches And Emerging Technologies

While base-catalyzed polymerization dominates industrial production, alternative synthetic routes offer advantages for specialized applications requiring narrow molecular weight distributions or specific end-group functionalities 3. Anionic polymerization using organometallic initiators (e.g., alkali metal alkoxides or organolithium compounds) provides enhanced control over molecular weight and polydispersity, achieving PDI values as low as 1.02-1.05 4. However, the requirement for rigorously anhydrous conditions and inert atmosphere increases production costs, limiting this approach to high-value pharmaceutical intermediates 3.

Enzymatic polymerization using lipases or esterases represents an emerging green chemistry approach for PEG synthesis, operating under mild conditions (30-50°C, atmospheric pressure) with high selectivity 7. These biocatalytic methods minimize side product formation and eliminate the need for toxic metal catalysts, though current reaction rates (typically 10-20% conversion per hour) remain slower than conventional chemical processes 6. Genetic engineering of enzymes with enhanced ethylene oxide tolerance and activity may improve commercial viability in future applications 7.

Continuous flow reactor technology offers improved process control and safety compared to traditional batch polymerization, particularly important given ethylene oxide's flammability and toxicity 6. Microreactor systems with precise temperature and residence time control enable production of PEG 300 with narrower molecular weight distributions (PDI 1.05-1.08) and reduced batch-to-batch variation 7. The smaller reactor volumes inherently limit the consequences of potential runaway reactions, addressing safety concerns in ethylene oxide processing 6. Scale-up of continuous flow processes for commodity PEG 300 production requires optimization of heat transfer and mixing efficiency in larger diameter tubular reactors 7.

Physical And Chemical Properties Of Polyethylene Glycol 300

PEG 300 exhibits a unique combination of physical properties that distinguish it from both lower and higher molecular weight polyethylene glycols 318. At room temperature (20-25°C), PEG 300 exists as a clear, colorless, viscous liquid with density 1.124-1.128 g/cm³, significantly higher than water due to the high oxygen content in the polymer backbone 1119. The viscosity ranges from 60-80 cP at 25°C, providing sufficient fluidity for pumping and mixing operations while maintaining low volatility (vapor pressure <0.01 mmHg at 20°C) 818. This low volatility minimizes evaporative losses during processing and storage, an important consideration for formulation stability 11.

The glass transition temperature (Tg) of PEG 300 occurs at 4-8°C, below which the material transitions from a supercooled liquid to an amorphous glassy state 18. Unlike higher molecular weight PEGs that exhibit distinct melting points (e.g., PEG 600 melts at 20-25°C, PEG 1500 at 44-48°C), PEG 300 remains liquid under normal ambient conditions, facilitating handling and processing 1718. The absence of crystallinity in PEG 300 at room temperature results from insufficient chain length to form stable crystalline domains, a characteristic shared with PEG 200 and PEG 400 811.

Hygroscopicity represents a defining characteristic of PEG 300, with equilibrium moisture uptake reaching 2-4 wt% at 50% relative humidity and 25°C 1119. This water absorption occurs through hydrogen bonding between atmospheric moisture and the ether oxygen atoms in the PEG backbone 3. While hygroscopicity benefits applications requiring humectant properties (cosmetics, pharmaceutical ointments), it necessitates moisture-controlled storage to prevent water contamination in moisture-sensitive formulations 816. Sealed containers with nitrogen or argon headspace effectively prevent moisture ingress during long-term storage 11.

Solubility And Compatibility Characteristics

PEG 300 demonstrates exceptional solubility in both aqueous and organic media, a rare property among polymeric materials 34. Complete miscibility with water occurs across all proportions, with dissolution being exothermic (ΔH ≈ -15 to -20 kJ/mol of ethylene oxide units) due to favorable hydrogen bonding interactions 79. Aqueous solutions of PEG 300 exhibit non-ideal behavior with negative deviations from Raoult's law, indicating stronger solute-solvent interactions than in pure components 11. The cloud point (temperature at which phase separation occurs) for PEG 300 aqueous solutions exceeds 100°C at concentrations up to 50 wt%, ensuring solution stability under typical processing conditions 8.

Organic solvent compatibility extends to alcohols (methanol, ethanol, isopropanol), ketones (acetone, methyl ethyl ketone), esters (ethyl acetate), chlorinated solvents (dichloromethane, chloroform), and aromatic hydrocarbons (toluene, xylene) 316. This broad solubility profile enables PEG 300 to function as a co-solvent or solubilizing agent in complex formulations containing both hydrophilic and lipophilic active ingredients 210. The mixed solution of PEG 300 with higher molecular weight PEGs (e.g., PEG 2000) exhibits enhanced drug compatibility and can extract both fat-soluble and water-soluble compounds from biological matrices 2. Immiscibility occurs with aliphatic hydrocarbons (hexane, heptane) and perfluorinated solvents, limiting applications in these solvent systems 8.

The dielectric constant of PEG 300 measures approximately 13-15 at 25°C and 1 kHz, intermediate between water (ε ≈ 80) and typical organic solvents (ε ≈ 2-10) 11. This moderate polarity contributes to PEG 300's effectiveness as a plasticizer for polar polymers and as a medium for electrochemical applications 8. Surface tension values of 43-45 mN/m at 25°C indicate moderate wetting ability on most substrates, though lower than water (72 mN/m), facilitating spreading and penetration in coating applications 19.

Chemical Stability And Reactivity Profile Of PEG 300

PEG 300 exhibits excellent chemical stability under normal storage and processing conditions, with minimal degradation over extended periods when protected from oxidative and thermal stress 37. The ether linkages in the polymer backbone resist hydrolysis under neutral pH conditions, maintaining molecular weight and functionality for years at ambient temperature 46. Accelerated stability testing at 40°C and 75% relative humidity for 6 months shows <2% change in molecular weight distribution and <5% increase in peroxide value for properly stabilized PEG 300 17. This inherent stability contributes to PEG 300's widespread use in pharmaceutical formulations requiring multi-year shelf life 710.

Oxidative degradation represents the primary degradation pathway for PEG 300, particularly under elevated temperatures, UV exposure, or in the presence of transition metal catalysts 617. Autoxidation proceeds through free radical mechanisms, generating hydroperoxides (-OOH) at carbon atoms adjacent to ether linkages, which subsequently decompose to form aldehydes, carboxylic acids, and chain scission products 17. Peroxide values in unstabilized PEG 300 can reach 50-100 meq/kg after 3 months storage at 40°C in air, compared to <5 meq/kg for antioxidant-stabilized grades 17. Incorporation of phenolic antioxidants (e.g., butylated hydroxytoluene at 0.01-0.1 wt%) or phosphite stabilizers effectively suppresses peroxide formation and extends product lifetime 17.

Thermal stability of PEG 300 permits processing at temperatures up to 150-180°C for short durations (<30 minutes) without significant degradation, though prolonged heating above 200°C induces ether cleavage and formation of volatile degradation products including acetaldehyde, formaldehyde, and ethylene glycol 718. Thermogravimetric analysis (TGA) shows onset of mass loss at approximately 180-200°C under nitrogen atmosphere, with 5% weight loss occurring at 220-240°C 17. In oxidative atmospheres (air), degradation initiates at lower temperatures (150-170°C) due to accelerated peroxide formation 6. These thermal stability limits guide selection of processing conditions for PEG 300-containing formulations 717.

Reactivity Of Terminal Hydroxyl Groups

The terminal hydroxyl groups of PEG 300 provide reactive sites for chemical modification, enabling synthesis of functionalized derivatives for specialized applications 39. Esterification reactions with carboxylic acids or acid chlorides proceed readily under standard conditions (80-120°C, acid catalyst or base scavenger), yielding PEG diesters with altered hydrophobicity and crystallinity 49. For example, reaction of PEG 300 with stearic acid (C₁₈ fatty acid) produces PEG 300 distearate, a waxy solid used as emulsifier and consistency regulator in cosmetic formulations 8. Esterification kinetics follow second-order behavior with rate constants typically 0.01-0.1 L/(mol·min) at 100°C, requiring 2-6 hours for >95% conversion 9.

Etherification reactions convert terminal hydroxyls to alkyl or aryl ethers, reducing hydrogen bonding capacity and enhancing compatibility with nonpolar matrices 34. Williamson ether synthesis using alkyl halides and strong bases (NaH, KOH) achieves high conversion (>90%) under reflux conditions in apr

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
DOW GLOBAL TECHNOLOGIES LLCPharmaceutical excipients and biomedical applications requiring low molecular weight impurities and compliance with pharmacopeial standards for drug formulations.High Purity Polyethylene Glycol 300Reduced oligomer concentration with ethylene glycol and diethylene glycol content limited to ≤0.25% (2,500 ppm), meeting USP specifications for pharmaceutical applications through vacuum distillation and molecular sieve separation purification processes.
BASF SEPharmaceutical excipients, cosmetic formulations, and industrial applications requiring water-soluble polymeric carriers with hygroscopic and plasticizing properties.Lutrol E300Commercial-grade PEG 300 with controlled molecular weight distribution (PDI 1.05-1.15) and average molecular weight 285-315 g/mol, providing consistent viscosity (60-80 cP at 25°C) and solubilization capacity for industrial formulations.
Resman ASClinical diagnostic methods for drug-addicted patient monitoring through urinalysis, leveraging PEG's non-metabolizable properties for accurate biomarker tracking.PEG Marker Diagnostic SystemUtilizes polydisperse PEG 300 containing oligomers (n=5 to 9) as non-metabolizable marker substances, analyzed by HPLC with RI detection for diagnostic monitoring applications.
VERTEX PHARMACEUTICALS INCORPORATEDPharmaceutical drug delivery systems requiring solubilization of hydrophobic compounds with improved stability and controlled release properties.PEG 400-Based Drug FormulationFormulation containing 40-60% by weight polyethylene glycol (PEG 300-1000 range) achieving enhanced drug solubilization and bioavailability for poorly water-soluble active pharmaceutical ingredients.
BIOTRONIK AGNon-crosslinked biological tissue treatment and preservation for medical device applications, particularly cardiovascular implants requiring maintained tissue integrity.Tissue Stabilization SolutionSequential application of PEG solutions with molecular weights from 150-300 g/mol (PEG 200) followed by higher molecular weight PEGs (400-600 g/mol), providing tissue preservation and stabilization without crosslinking.
Reference
  • Novel tracer materials
    PatentActiveEP3121368A1
    View detail
  • Method for extracting total flavonoids from stropharia rugoso-annulata
    PatentActiveZA202204298A
    View detail
  • Selective and Specific Preparation of Discrete Peg Compounds
    PatentActiveUS20110124844A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png